Association between proprotein convertase subtilisin/kexin type 9 targeted therapies and the risk of arrhythmias: a meta-analysis of randomized controlled trials
Authors
Aman Goyal (ORCID: https://orcid.org/0000-0001-8062-5657)
Association between proprotein convertase subtilisin/kexin type 9 targeted therapies and the risk of arrhythmias: a meta-analysis of randomized controlled trials
Aman Goyal, Anupam Halder, Maciej Banach, Vivek Mittal et al.
Citations
1 citations
Journal
American Journal of Preventive Cardiology
Topics
Lipoproteins and Cardiovascular Health
Field-Weighted Citation Impact (FWCI)
2.01
article
Association between proprotein convertase subtilisin/kexin type 9 targeted therapies and the risk of arrhythmias: a meta-analysis of randomized controlled trials
Aman Goyal, Anupam Halder, Maciej Banach, Vivek Mittal, Novonil Deb, Sulochana Khadka, Raheel Ahmed, Vikash Jaiswal, Ibadete Bytyçi, Nishat Shama, Tushar Kumar, Kripa Rajak
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
American Journal of Preventive CardiologyVol. 24
Institutions
John Paul II Catholic University of Lublin (PL), Trinity Health (US), Cleveland Clinic (US), Mount Sinai Hospital (US), Johns Hopkins University (US), University of Liverpool (GB), King Edward Memorial Hospital and Seth G.S. Medical College (IN), University of Washington (US), Johns Hopkins Medicine (US), UPMC Central Pa (US), Henry Ford Hospital (US), North Bengal Medical College and Hospital (IN), Liverpool Heart and Chest Hospital (GB), University Clinical Center of Kosovo (XK), AMA Computer University (PH), Mount Sinai Medical Center (US), Medical University of Lodz (PL), Polish Mother’s Memorial Hospital Research Institute (PL), Imperial College London (GB), Liverpool John Moores University (GB), University of Missouri (US), University of Prishtina (XK), Jackson College (US)